Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Distribution Analysis of Candida albicans according to Sex and Age in Clinical Specimen Testing for Sexually Transmitted Diseases

  • Jae Eun Choi (Department of Public Health Science, Dankook University Graduate School) ;
  • Jae-Sik Jeon (Department of Biomedical Laboratory Science, Dankook University College of Health Sciences) ;
  • Jae Kyung Kim (Department of Biomedical Laboratory Science, Dankook University College of Health Sciences)
  • Received : 2022.08.17
  • Accepted : 2022.10.26
  • Published : 2023.01.28
Download PDF
⟨ Previous Next ⟩

Abstract

The prevalence of candidiasis, a contagious disease with high morbidity and mortality, has sharply increased globally over the last two decades. Candida albicans can cause serious infections in patients with weak immunity and in recipients of prolonged antibiotic treatment. Consequently, rapid and accurate identification of species can play an important role in the treatment of candidiasis. Here, we investigated the positive rate and infection trend of C. albicans according to age, specimen type, and sex using multiplex real-time polymerase chain reaction-based testing of samples collected for the diagnosis of sexually transmitted diseases in Korea between 2018 and 2020. When the type of specimen collected was a swab, the positive rate of C. albicans was higher among younger women, and tended to decrease with age. Analysis of swab samples revealed higher positive rates than urinalysis. The reduction trend in positive rates by age was comparable between the overall samples and urine specimens. Among male patients, the positive rate did not differ substantially across the various types of specimens collected. Previous studies have shown a higher prevalence of non-albicans Candida species than C. albicans in clinical specimens, and exclusion of the former from our analysis may be a limitation of this study. However, our findings contribute significantly to the literature because globally, there is a paucity of epidemiological studies using molecular techniques to detect C. albicans in sexually transmitted disease test samples.

Keywords

References

  1. Talapko J, Juzbasic M, Matijevic T, Pustijanac E, Bekic S, Kotris I, et al. 2021. Candida albicans-the virulence factors and clinical manifestations of infection. J. Fungi 7: 79.
  2. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39: 309-317. https://doi.org/10.1086/421946
  3. Idelevich EA, Grunewald CM, Wullenweber J, Becker K. 2014. Rapid identification and susceptibility testing of Candida spp. from positive blood cultures by combination of direct MALDI-TOF mass spectrometry and direct inoculation of Vitek 2. PLoS One 9: e114834.
  4. Buder S and Lautenschlager S. 2020. Gonorrhea and urethritis, pp. 1-8. In Landthaler M, Plewig G, Burgdorf WHC, WolffPlewig H (eds.), Braun-Falco's Dermatology. Springer Germany, Berlin.
  5. Bukhary Z. 2008. Candiduria: a review of clinical significance and management. Saudi J. Kidney Dis. Transpl. 19: 350-360.
  6. Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins BA, Stephens DS, et al. 1999. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin. Infect. Dis. 29: 1164-1170. https://doi.org/10.1086/313450
  7. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. 1988. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch. Intern. Med. 148: 2642-2645. https://doi.org/10.1001/archinte.1988.00380120094019
  8. Kim GY, Jeon JS, Kim JK. 2016. Isolation frequency characteristics of Candida species from clinical specimens. Mycobiology 44: 99-104. https://doi.org/10.5941/MYCO.2016.44.2.99
  9. Zeng X, Zhang Y, Zhang T, Xue Y, Xu H, An R. 2018. Risk factors of vulvovaginal candidiasis among women of reproductive age in Xi'an: A cross-sectional study. Biomed. Res. Int. 2018: 9703754.
  10. Holland J, Young ML, Lee O, C-A Chen, S. 2003. Vulvovaginal carriage of yeasts other than Candida albicans. Sex. Transm. Infect. 79: 249-250. https://doi.org/10.1136/sti.79.3.249
  11. Gottfredsson M, Cox GM, Perfect JR. 1998. Molecular methods for epidemiological and diagnostic studies of fungal infections. Pathology 30: 405-418. https://doi.org/10.1080/00313029800169726
  12. Sullivan DJ, Henman MC, Moran GP, O'Neill LC, Bennett DE, Shanley DB, et al. 1996. Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species. J. Med. Microbiol. 44: 399-408. https://doi.org/10.1099/00222615-44-6-399
  13. Pujol C, Joly S, Lockhart SR, Noel S, Tibayrenc M, Soll DR. 1997. Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans. J. Clin. Microbiol. 35: 2348-2358. https://doi.org/10.1128/jcm.35.9.2348-2358.1997
  14. Shin JH, Kook H, Shin DH, Hwang TJ, Kim M, Suh SP, et al. 2000. Nosocomial cluster of Candida lipolytica fungemia in pediatric patients. Eur. J. Clin. Microbiol. Infect. Dis. 19: 344-349. https://doi.org/10.1007/s100960050491
  15. Alhussaini MS, El-Tahtawi NF, Moharram AM. 2013. Phenotypic and molecular characterization of Candida species in urine samples from renal failure patients. Sci. J. Clin. Med. 2: 14-25. https://doi.org/10.11648/j.sjcm.20130201.13
  16. Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, McKinsey DS, Karchmer AW, et al. 2000. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin. Infect. Dis. 30: 14-18. https://doi.org/10.1086/313583
  17. Lal S, Parkash O, Kumar P, Malik ZA. 2021. Determination of predisposing factors in developing Candida albicans associated urinary tract infection and antifungal sensitivity profile. J. Pharm. Res Int. 33: 40-49. https://doi.org/10.9734/jpri/2021/v33i631188
  18. Jain M, Dogra V, Mishra B, Thakur A, Loomba PS, Bhargava A. 2011. Candiduria in catheterized intensive care unit patients: emerging microbiological trends. Indian J. Pathol. Microbiol. 54: 552-555. https://doi.org/10.4103/0377-4929.85091
  19. Mohammed TK, Wahab KM, Jawad MA. 2019. Isolation and identification of Candida albicans in different clinical samples. AlNisour J. Med. Sci. 1: 85-97.
  20. Marak MB, Dhanashree B. 2018. Antifungal susceptibility and biofilm production of Candida spp. isolated from clinical samples. Int. J. Microbiol. 2018: 7495218.
  21. Ghasemi R, Rabiei MM, Lotfali E, Abolghasemi, S, Ansari S. 2020. Candiduria: prevalence, identification of isolated Candida species and trends in antifungal susceptibility in hospitalized patients. Nov. Biomed. 8: 71-76.
  22. Jeon JS, Kim JK. 2019. Analysis of the distribution and antifungal susceptibility of Candida albicans and non-albicans Candida isolated from human blood culture. AMJ 12: 90-97. https://doi.org/10.21767/AMJ.2018.3572
  23. Espinosa-Hernandez VM, Morales-Pineda V, Martinez-Herrera E. 2020. Skin infections caused by emerging Candida species. Curr. Fung. Infect. Rep. 14: 99-105. https://doi.org/10.1007/s12281-020-00380-9
  24. Avcioglu F, Sirmatel F, Behcet M, Ozarslan TO, Gozdas HT. 2021. Investigation of a healthcare-associated candida infections in a Turkish intensive care unit: risk factors, therapy and clinical outcome. Exp. Biomed. Res. 4: 9-15. https://doi.org/10.30714/j-ebr.2021165773